Susquehanna International Group’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.74M Buy
8,517
+6,174
+264% +$1.91M ﹤0.01% 5454
2025
Q4
$691K Sell
2,343
-26,994
-92% -$5.03M ﹤0.01% 8059
2025
Q3
$1.55M Sell
29,337
-17,590
-37% -$853K ﹤0.01% 6327
2025
Q2
$1.97M Buy
46,927
+12,179
+35% +$464K ﹤0.01% 5816
2025
Q1
$1.32M Sell
34,748
-123,177
-78% -$7.69M ﹤0.01% 6556
2024
Q4
$12.2M Buy
157,925
+128,931
+445% +$9.33M ﹤0.01% 2419
2024
Q3
$1.67M Buy
+28,994
New +$1.57M ﹤0.01% 5667
2024
Q2
Sell
-106,159
Closed -$5.02M 12973
2024
Q1
$6.48M Buy
106,159
+57,875
+120% +$2.6M ﹤0.01% 3220
2023
Q4
$1.08M Buy
48,284
+34,499
+250% +$621K ﹤0.01% 6822
2023
Q3
$354K Buy
13,785
+3,675
+36% +$69.5K ﹤0.01% 9002
2023
Q2
$174K Buy
10,110
+3,155
+45% +$48.3K ﹤0.01% 10418
2023
Q1
$84.4K Buy
6,955
+5,608
+416% +$237K ﹤0.01% 11405
2022
Q4
$48.1K Sell
1,347
-970
-42% -$30.3K ﹤0.01% 11423
2022
Q3
$79K Sell
2,317
-2,621
-53% -$131K ﹤0.01% 11896
2022
Q2
$181K Buy
4,938
+3,726
+307% +$398K ﹤0.01% 10783
2022
Q1
$186K Sell
1,212
-565
-32% -$116K ﹤0.01% 11318
2021
Q4
$525K Buy
+1,777
New +$521K ﹤0.01% 9060

Other funds holding PRAX

Susquehanna International Group's PRAX Position: Q1 2026 in Review

Susquehanna International Group increased its Praxis Precision Medicines (PRAX) stake by 264% in Q1 2026, buying an estimated $1.91M and bringing the position to 8,517 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #5454.

Susquehanna International Group first reported a position in PRAX in Q4 2021 and has held it in 17 quarters since. The position peaked at $12.2M in Q4 2024. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Susquehanna International Group held 8,517 shares of Praxis Precision Medicines worth $2.74M as of Q1 2026.
  • Susquehanna International Group bought 6,174 Praxis Precision Medicines shares in Q1 2026, an estimated $1.91M.
  • Praxis Precision Medicines made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5454 holding.
  • Susquehanna International Group first reported a position in Praxis Precision Medicines in Q4 2021 and has held it in 17 quarters since.
  • Susquehanna International Group's Praxis Precision Medicines position peaked at $12.2M in Q4 2024.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.